Management Team


Rick Bunker


Rick is a co-founder and the CEO of Prescription Advisory. In this role, he is responsible for capital formation and corporate development.

Rick brings over 25 years of executive experience to Prescription Advisory, specializing in general management and software development team leadership, especially in venture and PE backed companies. He has held executive level technology positions for three publicly traded companies – SEIC, ICGE, GSIC (now a division of eBay) – and was CEO of Reality Online, a Reuter’s subsidiary that was a pioneer in internet delivery of consumer financial services.

In addition to his technology leadership, Rick has worked on over 100 M&A transactions. He is a veteran of the United States Army Security Agency, a graduate of the Defense Language Institute and attended Boston University — studying Russian Language and Literature. In his personal time, Rick is active in local politics and is Vice President of the Jenkintown Borough Council and serves on the Jenkintown Human Relations Committee.


Eric Corkhill

President/Chief Revenue Officer

Eric joined full time in August 2016. Over the past 30 years, Eric has aggressively grown startup companies and accelerated growth of existing organizations. Eric has expertise in both the payor and provider healthcare sectors with proven ability to create markets for new products or to expand market penetration and client satisfaction of established products. He has successfully established new sales processes utilizing best practices and performance driven metrics throughout his career. He has managed both direct sales and complex sales channels and developed multi-tiered marketing strategies while enhancing client retention and revenue contribution. For five years prior to joining Prescription Advisory, Eric was the Chief Revenue Officer at Notifi Health LLC. Prior to Notifi Health, Eric was Vice President of Sales and Marketing for HIT Application Solutions (5 years), a company aimed at allowing physicians to provide better care via technology. Eric is a graduate of the University of Virginia with a Bachelor of Arts in Art History, Marketing and Biology-1980.


David Stengle

Chief Marketing Officer

David brings over 25 years of executive experience to Prescription Advisory, specializing in enterprise software and transactional systems. Prior to Prescription Advisory, David spent a decade at BlackArrow, where he ran business development including channel sales and strategic partnerships. He developed strategic relations resulting in investment leads for multiple rounds of funding.

Prior to BlackArrow, David worked mostly with private equity companies including serving as CEO of Starnet, another ad tech company. He started as a software developer.

David’s enthusiasm for startups extends beyond Prescription Advisory. He is the Director of Startup Grind Princeton and a mentor for the Princeton University eLab.


Vincent Mendola

Chief Financial Officer

Vince earned his CPA (NJ) in 1989 and MBA in finance from Drexel University in 1994. He brings experience in the areas of business turnaround, top and bottom line growth, acquisitions and financing (bank/SBA) for businesses ranging from $10 to $75 million in sales.

Prior experiences include CFO – Rhoads Industries (7 years-industrial services & metal fabrication), CFO – Advertising Specialty Institute (3 years -technology and publishing), CFO/COO – Reality On-Line (a Reuters company-5 years- information and technology), CFO/COO – Thomas Cook USA (10 years – financial services). Vince was also the controller for Medical Resources, Inc., a public company involved in the roll-up of hundreds of radiology practices between 1994 and 1998.

Follow Prescription Advisory

A study was conducted to estimate the societal costs of prescription opioid abuse, dependence, and misuse in the United States. Costs were grouped into three categories: health care, workplace, and criminal justice.

The results: Total US societal costs of prescription opioid abuse were estimated at $55.7 billion in 2007 (USD in 2009). Workplace costs accounted for $25.6 billion, health care costs accounted for $25.0 billion, and criminal justice costs accounted for $5.1 billion. Workplace costs were driven by lost earnings from premature death ($11.2 billion) and reduced compensation/lost employment ($7.9 billion).

Conclusions: The costs of prescription opioid abuse represent a substantial and growing economic burden for the society. The increasing prevalence of abuse suggests an even greater societal burden in the future.

Pain Medicine, Volume 12, Issue 4, April 2011

An improved PDMP … with accurate and timely data analysis should be regarded as the cornerstone of our collective efforts to address prescription drug abuse.

Department of Public Health
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This